1. A multiple testing procedure for multi-dimensional pairwise comparisons with application to gene expression studies. Issue 1 (December 2016) Authors: Grandhi, Anjana; Guo, Wenge; Peddada, Shyamal Journal: BMC bioinformatics Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine. (1st September 2022) Authors: Molina, Jean-Michel; Yazdanpanah, Yazdan; Afani Saud, Alejandro; Bettacchi, Christopher; Chahin Anania, Carolina; Klopfer, Stephanie O.; Grandhi, Anjana; Eves, Karen; Hepler, Deborah; Robertson, Michael N.; Hwang, Carey; Hanna, George J.; Correll, Todd Journal: Journal of acquired immune deficiency syndromes Issue: Volume 91:Number 1(2022) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial. Issue 6 (June 2021) Authors: Molina, Jean-Michel; Yazdanpanah, Yazdan; Afani Saud, Alejandro; Bettacchi, Christopher; Chahin Anania, Carolina; DeJesus, Edwin; Olsen Klopfer, Stephanie; Grandhi, Anjana; Eves, Karen; Robertson, Michael N; Correll, Todd; Hwang, Carey; Hanna, George J; Sklar, Peter Journal: Lancet Issue: Volume 8:Issue 6(2021) Page Start: e324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Issue 10273 (6th February 2021) Authors: Maertens, Johan A; Rahav, Galia; Lee, Dong-Gun; Ponce-de-León, Alfredo; Ramírez Sánchez, Isabel Cristina; Klimko, Nikolay; Sonet, Anne; Haider, Shariq; Diego Vélez, Juan; Raad, Issam; Koh, Liang-Piu; Karthaus, Meinolf; Zhou, Jianying; Ben-Ami, Ronen; Motyl, Mary R; Han, Seongah; Grandhi, Anjana; ... Journal: Lancet Issue: Volume 397:Issue 10273(2021) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia. Issue 9 (September 2018) Authors: Arrieta, Antonio C.; Bradley, John S.; Popejoy, Myra W.; Bensaci, Mekki; Grandhi, Anjana; Bokesch, Paula; Glasser, Chad; Du, Lihong; Patino, Hernando; Kartsonis, Nicholas A. Journal: Pediatric infectious disease journal Issue: Volume 37:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials. (November 2017) Authors: Lawitz, Eric; Buti, Maria; Vierling, John M; Almasio, Piero L; Bruno, Savino; Ruane, Peter J; Hassanein, Tarek I; Muellhaupt, Beat; Pearlman, Brian; Jancoriene, Ligita; Gao, Wei; Huang, Hsueh-Cheng; Shepherd, Aimee; Tannenbaum, Brynne; Fernsler, Doreen; Li, Jerry J; Grandhi, Anjana; Liu, Hong; Su... Journal: Lancet gastroenterology and hepatology Issue: Volume 2:Number 11(2017) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials. (November 2017) Authors: Gane, Edward J; Pianko, Stephen; Roberts, Stuart K; Thompson, Alexander J; Zeuzem, Stefan; Zuckerman, Eli; Ben-Ari, Ziv; Foster, Graham R; Agarwal, Kosh; Laursen, Alex L; Gerstoft, Jan; Gao, Wei; Huang, Hsueh-Cheng; Fitzgerald, Brian; Fernsler, Doreen; Li, Jerry J; Grandhi, Anjana; Liu, Hong; Su,... Journal: Lancet gastroenterology and hepatology Issue: Volume 2:Number 11(2017) Page Start: 805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗